VR
Venkateswara Reddy Appireddy
About Venkateswara Reddy Appireddy
Data last updated:
Venkateswara Reddy Appireddy is a Managing Director at Monograph Pharma Private Limited (since 2022) and Director at Zeino Pharma India Private Limited (since 2025). The companies operate in Food And Beverages and Consumer Services. The largest current company by reported revenue is Monograph Pharma Private Limited at ₹88,500 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Monograph Pharma Private Limited U46497TG2022PTC168215 | Managing Director | 13 Nov 2022 | 2022 | ₹88,500 (FY 2025) | Active |
| Zeino Pharma India Private Limited U46497TS2025FTC203095 | Director | 28 Aug 2025 | 2025 | Active |
Board colleagues of Venkateswara Reddy Appireddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lokanadha Reddy Ketham Reddy | 06919399 | Monograph Pharma Private Limited | Director |
| Mohamed Jijish | 11054489 | Monograph Pharma Private Limited , Zeino Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkateswara Reddy Appireddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkateswara Reddy Appireddy
Venkateswara Reddy Appireddy currently holds 2 directorships: Monograph Pharma Private Limited (Managing Director, since 13 Nov 2022, revenue ₹88,500 (FY 2025)); Zeino Pharma India Private Limited (Director, since 28 Aug 2025).
Venkateswara Reddy Appireddy was first appointed on 13 Nov 2022 as Managing Director at Monograph Pharma Private Limited. The most recent appointment on record is 28 Aug 2025 at Zeino Pharma India Private Limited.
The current boards of Venkateswara Reddy Appireddy's companies include Lokanadha Reddy Ketham Reddy (Monograph Pharma Private Limited), Mohamed Jijish (Monograph Pharma Private Limited).